Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
November 17th, 2021
3.3K views
Recent works uncover the neuronal impact on high-grade pediatric glioma (pHGG) cells and their reciprocal interactions. The present work shows the development of an in vitro model co-culturing pHGG cells and glutamatergic neurons and recorded their electrophysiological interactions to mimic those interactivities.
Overview
This study investigates the interactions between high-grade pediatric glioma (pHGG) cells and glutamatergic neurons using an in vitro co-culture model. The research highlights the use of microfluidic devices and multielectrode arrays to record electrophysiological interactions, providing insights into the functional dynamics of these cell types.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Electrophysiology
Background
- High-grade pediatric gliomas are aggressive brain tumors.
- Interactions between glioma cells and neurons can influence tumor behavior.
- Understanding these interactions may lead to new therapeutic strategies.
- In vitro models are essential for studying complex cell interactions.
Purpose of Study
- To develop a co-culture model of pHGG cells and glutamatergic neurons.
- To record and analyze electrophysiological interactions between these cell types.
- To explore the effects of pharmacological agents on cell migration and interaction.
Methods Used
- Development of an in vitro co-culture system using microfluidic devices.
- Utilization of multielectrode arrays for electrical activity recordings.
- Pharmacological testing to assess the impact on glioma cell migration.
- Step-by-step protocol for culturing human IPS-derived cortical neurons.
Main Results
- Successful co-culture of pHGG cells and glutamatergic neurons.
- Electrophysiological recordings revealed significant interactions.
- Pharmacological agents effectively blocked glioma cell migration.
- The model provides insights into the tumor-neuron communication.
Conclusions
- The in vitro model is a valuable tool for studying glioma-neuron interactions.
- Findings may inform future therapeutic approaches for pediatric gliomas.
- Further research is needed to explore the underlying mechanisms.
Frequently Asked Questions
What is the significance of studying pHGG cells?
Understanding pHGG cells can lead to better treatment strategies for aggressive pediatric brain tumors.
How does the co-culture model work?
The model allows for the simultaneous growth of glioma cells and neurons, enabling the study of their interactions.
What techniques are used to record cell interactions?
Electrophysiological recordings are made using multielectrode arrays integrated into microfluidic devices.
What are the implications of pharmacological testing?
Pharmacological testing can identify potential treatments that inhibit glioma cell migration and interaction with neurons.
Why use human IPS-derived neurons?
Human IPS-derived neurons provide a relevant model for studying human brain cell interactions.
What future research directions are suggested?
Future research should focus on the mechanisms of tumor-neuron communication and potential therapeutic targets.
Executive Industry Relevance
Modeling tumor-neuron interactions in pediatric high-grade glioma addresses a critical gap in understanding microenvironment-driven treatment resistance. This microfluidic co-culture system enables quantitative assessment of electrophysiological changes, supporting mechanistic de-risking of neuro-oncology targets. The approach provides predictive value for screening compounds that modulate glioma cell migration and neuronal excitability.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of glutamatergic neuron hyperexcitability as a functional readout of tumor-neuron signaling.
- Operational Value: Supports validation of targets involved in neuronal activity modulation using patient-derived glioma lines.
- Scientific Value: Facilitates pathway clarification by linking glioma cell presence to measurable changes in neuronal spike frequency.
Screening & Assay Development
- Scientific Value: Generates quantitative electrophysiological outputs via multielectrode arrays for compound screening.
- Operational Value: Standardizes co-culture conditions in compartmentalized microfluidic devices for reproducible assay performance.
- Scientific Value: Enables time-resolved monitoring of electrical activity changes pre- and post-glioma co-culture.
Translational & Preclinical Research
- Scientific Value: Uses disease-relevant human iPSC-derived neurons and pediatric glioma lines to enhance translational fidelity.
- Operational Value: Maintains physiological microenvironment to support preclinical evaluation of pharmacological agents.
- Scientific Value: Supports biomarker alignment by correlating tumor cell adherence with neuronal hyperexcitability.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by providing a functional readout for target engagement in neuro-oncology programs, bridging phenotypic screening and lead optimization.
- Discovery Biology: Supports hypothesis testing of tumor-induced neuronal network dysregulation via spike detection and raster plot analysis.
- Screening: Delivers assay readiness through standardized electrophysiological recordings at defined time points (day 21 and 23).
- Analytics: Provides quantitative dependent variable measurements (instantaneous firing rate, spike frequency) to compare co-culture versus control conditions.
- Translational Research: Connects to preclinical continuity by using patient-derived cell lines and human neurons to model clinically relevant interactions.
- Enterprise Reuse: Establishes a reusable platform for testing multiple glioma lines and neuron types across therapeutic modalities.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by demonstrating significant electrophysiological changes upon tumor cell introduction.
- Operational Value: Ensures reproducibility through standardized medium changes, cell seeding protocols, and environmental controls.
- Strategic Value: Improves go/no-go decisions by identifying compounds that block glioma-neuron interaction and migration.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on functional impact on neuronal network activity.
Implementation Considerations
- Requires expertise in stem cell differentiation, microfluidic handling, and electrophysiological recording.
- Dependent on multielectrode array-compatible microfluidic devices and imaging systems for viability assessment.
- Necessitates cross-team standardization between cell culture, electrophysiology, and data analysis teams.
- Involves adaptation considerations when extending to other neuron or tumor types beyond cortical glutamatergic neurons and UW479/BT35 lines.
- Limited by the two-day co-culture window, which may not capture long-term adaptive changes in neuronal networks.
Biopharma FAQs
Why does null hypothesis testing matter for validating glutamatergic neuron excitability changes?
Null hypothesis testing determines whether observed increases in neuronal spike frequency after glioma co-culture are statistically significant, supporting target validation by distinguishing true biological effects from variability in electrophysiological recordings.
How does isolating the independent variable (glioma cell presence) fit the neuro-oncology discovery pipeline?
Isolating glioma cell introduction as the independent variable allows researchers to attribute changes in neuronal activity specifically to tumor-neuron interaction, enabling mechanistic de-risking of targets involved in microenvironment signaling.
What quantitative dependent variable measurements enable assessment of neuronal network effects?
Measurements such as instantaneous firing rate and spike detection via multielectrode arrays provide quantitative outputs to compare electrical activity between control and co-cultured glutamatergic neurons, supporting screening of pharmacological modulators.
Why do replication requirements matter for cross-functional collaboration in this model?
Replicating electrophysiological recordings across multiple microfluidic devices and time points ensures data reliability, enabling consistent interpretation by biology, pharmacology, and analytics teams during target prioritization.
What statistical analysis capabilities are required before implementing this co-culture system for compound screening?
Implementation requires capability to perform spike detection, raster plot generation, and statistical comparison of firing rates between conditions to determine significant differences in neuronal excitability following glioma cell exposure.
